Indivior Pharmaceuticals, Inc. - INDV
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Aug 27, 2026 | Chief Accounting Officer | P | A | 1,500.0 | 35.69 | 53,535.0 | 27,638.0 | View | |
| Aug 05, 2026 | Chief Accounting Officer | P | A | 1,500.0 | 36.28 | 54,420.0 | 26,138.0 | View | |
| Jul 13, 2026 | Chief Scientific Officer | S | D | 18,586.0 | 41.14 | 764,628.04 | 209,337.0 | View | |
| Jun 23, 2026 | Chief Executive Officer | M | D | 1,266,903.0 | — | — | 0.0 | View | |
| Jun 23, 2026 | Chief Executive Officer | F | D | 612,549.0 | 38.32 | 23,472,877.68 | 790,330.0 | View | |
| Jun 23, 2026 | Chief Executive Officer | M | A | 1,266,903.0 | — | — | 1,402,879.0 | View | |
| Jun 12, 2026 | Chief Scientific Officer | S | D | 18,586.0 | 38.06 | 707,383.16 | 227,923.0 | View | |
| Jun 10, 2026 | Chief Financial Officer | S | D | 36,000.0 | 37.7 | 1,357,200.0 | 284,751.0 | View | |
| May 14, 2026 | — | A | A | 6,518.0 | 0.0 | 0.0 | 16,042.0 | View | |
| May 14, 2026 | — | A | A | 6,518.0 | 0.0 | 0.0 | 12,973.0 | View | |
| May 14, 2026 | — | F | D | 1,117.0 | 38.28 | 42,758.76 | 6,455.0 | View | |
| May 14, 2026 | — | A | A | 6,518.0 | 0.0 | 0.0 | 12,100.0 | View | |
| May 14, 2026 | — | A | A | 6,518.0 | 0.0 | 0.0 | 27,163.0 | View | |
| May 14, 2026 | — | A | A | 6,518.0 | 0.0 | 0.0 | 12,242.0 | View | |
| May 14, 2026 | — | A | A | 6,518.0 | 0.0 | 0.0 | 27,087.0 | View | |
| May 14, 2026 | — | A | A | 10,430.0 | 0.0 | 0.0 | 30,780.0 | View |